Abstract Guanylyl cyclases (GCs), a ubiquitous family of enzymes that metabolize GTP to cyclic GMP (cGMP), are traditionally divided into membrane-bound forms (GC-A-G) that are activated by peptides and cytosolic forms that are activated by nitric oxide (NO) and carbon monoxide. However, recent data has shown that NO activated GC's (NOGC) also may be associated with membranes. In the present study, interactions of guanylyl cyclase A (GC-A), a caveolae-associated, membrane-bound, homodimer activated by atrial natriuretic peptide (ANP), with NOGC, a heme-containing heterodimer (a/b) b1 isoform of the b subunit of NOGC (NOGCb1) was specifically focused.
specificities, membrane-bound GCs have been classified into natriuretic peptide GC receptors (GC-A and GC-B), intestinal peptide-binding receptors (GC-C), and orphan receptors, (GCD-GCG) [4] . GC-A and GC-B, principal receptors for atrial natriuretic peptide (ANP), are generally accepted to be homodimers consisting of subunit of approx 115 kDa with highly conserved regions, including an extra cellular ligand binding domain important in ANP binding; a single transmembrane domain; a cytoplasmic juxtamembrane domain; a regulatory domain consisting of kinase homology domain (KHD); a hinge region required for dimerization; and a C-terminal catalytic domain which catalyzes the synthesis of cGMP [5] [6] [7] . Although GC-A exists as monomers and oligomers, it is generally accepted that only the dimer is activated by ANP [8] [9] [10] . GC-B was first identified by E. Page and demonstrated to be caveolinassociated and expressed in caveolae [11] .
NOGCs are a ubiquitous family of heme-containing heterodimers (a and b subunits of approx 80 and 72 kDa, respectively) [12, 13] . Two isoforms of each subunit, i.e., (a1, a2, b1, and b2) have been identified with the a1/b1 heterodimer considered the universal form. Both a and b subunits contain an amino-terminal domain important in heme binding; a central dimerization domain required for subunit association; and a carboxyl terminal catalytic domain. Although originally isolated from cytosol, NOGC has more recently been detected in cells membranes [14, 15] and a functional membrane caveolae-associated NOGC and PKG signaling complex identified in both rat aortic and corpus cavernosum endothelial cells [16, 17] .
Recently, complex multi-protein caveolae-associated interactive ''signaling complexes'' have been determined. This signaling complex includes, eNOS [18] , GC-A [11] , cGK [19] , caveolin-1 [20] , heat shock protein 90 (HSP90) [21] , eNOS interacting protein (NOSIP) [22] , and dynamin-2 [23] . The localization of both NOGCbeta1 and ANPstimulated guanylyl cyclase in membrane caveolae raises the possibility that NOGC influences GC-A signaling. As a first step toward investigating this possibility, we determined whether the b1 subunit of NOGC (NOGCb1) was capable of interacting with GC-A and whether an effect of NOGCb1 on GC-A activity could be detected in HK-2 cells.
Materials and methods
Isobutyl methyl xanthine (IBMX) and ANP were purchased from Sigma Chemical (St. Louis, MO). N (G)-Nitro-L-Arginine Methyl Ester (L-NAME) and H-3048 were obtained from Calbiochem Gibbstown, NJ) and Bachem Inc (Torrance, CA), respectively. siRNA duplex oligonucleotides r (GAGGC-ACAGUUA GAU GAAG) d (TT), r (CUUC AUCUA ACUG UGCC UC d (TT) directed against amino-terminal portion of NOGCb1 were synthesized by Qiagen (Valencia, CA). NOGCb1 and GC-A polyclonal antibodies were purchased from FabGennix Inc (Frisco, TX). Rabbit polyclonal Ab for caveolin, and rabbit anti-69 HIS polyclonal primary antibodies were from Upstate and Abcam, respectively. Cultured Human kidney-2 (HK-2) cells, (ATCC) were used at early passages and cultured in DMEM F12 medium supplemented with 10% fetal bovine serum under 5% CO 2 .
Transfections
Plasmids coding for full-length cDNAs of rat NOGCb1 and GC-A were kindly provided by Dr. David Garbers (Dallas, TX). Expression plasmid for full length NOGCb1 with yellow fluorescent protein (YFP) at the C-terminal end (pIRES-NOGCb1-EYFP) for use in immunofluorescence experiments was generated by cloning NOGCb1 into pIRES-EYFP (Clontech Inc) at EcoRV and Nco1 sites. In order to generate expression plasmids for use in transient transfection assays, cDNAs for NOGCb1 and GC-A were PCR amplified by using gene specific primers and the PCR products were cloned in Hind III and Bam HI sites of cDNA 3.1 vector. Transient transfection of HK-2 cells was performed using lipofectamine 2,000 reagent (Invitrogen/life technologies). Briefly, cells were plated in a six well plate at the density of 1.8 9 10 6 cells per plate and transfected 24 h after plating using lipofectamine 2000 as per manufacturer's instructions. Transfections with siRNA duplexes were carried out with trans messenger transfect reagent (Qiagen).
Immunoprecipitation (IP)
HK-2 cells were harvested from 10 cm 2 tissue culture dishes and cell pellets lysed in RIPA buffer (25 mM TrisHCl-pH 7.6, 150 mM NaCl, 1% non-idet P-40, 0.5% sodium deoxycholate, 0.1% SDS). Cell extracts were mixed with GC-A antibody (1 mg/ml) (FabGennix) and incubated at 4°C with continuous shaking overnight. Protein A/G agarose beads (20 ll) were added and incubated for 2 h with continuous shaking. The beads were washed with 1% Triton-X-100 in PBS, 0.5% Triton-X-100 in PBS, and 0.05% Triton-X-100 in PBS, respectively, resuspended in SDS sample loading buffer, and subjected to SDS PAGE followed by a western blot with NOGCb1 antibodies.
Immunofluorescence HK-2 cells were cultured in 2-well chamber slides at a density of *10,000 cells/cm 2 in Dulbecco's modified Eagle's medium with 10% Fetal bovine serum and 1% penicillin/streptomycin solution. Forty-eight hours after transfection cells were fixed in 3% Para formaldehyde and permeabilized with 1% Triton-X-100 in phosphate-buffered saline for 10 min. Fixed slides were incubated with a primary antibody mixture containing anti 69 HIS polyclonal primary antibody for 1 h (as GCA expression plasmid has the 6-His tag fused to its carboxyl terminus) followed by incubation in Alexa fluor 405-conjugated anti-mouse secondary antibody to detect GC-A signal. Expression of NOGCb1 was detected by yellow fluorescence. To appreciate the merger signals, they were assigned pseudo colors red for GC-A staining and green for NOGCb1. Confocal images were obtained using Zeiss laser-scanning confocal microscope LSM 510 META in multi-tracking mode to prevent interference of the dyes.
cGMP and guanylyl cyclase activity assays Intracellular cGMP was measured in cultured cells pretreated with IBMX (1 mM 9 1 h), a broad spectrum phosphodiesterase inhibitor that prevents degradation of cGMP by PDEs. Cells were lysed with three cycles of freezing in liquid nitrogen for 5 min and thawing at 37°C for 5 min. cGMP was measured using a commercially available enzyme immuno assay (EIA) Direct cGMP kit (Assay Design Inc (Ann Arbor, MI)). Intracellular cGMP was normalized to total protein determined by Bradford.
Guanylyl cyclase activity was measured in whole cell membranes as previously described [24] . Membranes were isolated as follows. Cells from numbers 5-6 150-mm 2 dishes were washed twice with 5 ml chilled phosphate-free buffer (2.36 M NaCl, 0.54 M NaHCO 3 , 0.4 M KCl, and 0.12 M MgCl 2 scraped in phosphate-free buffer) and centrifuged at 3,000g for 8-10 min. The cells were then placed on ice and lysed by dounce homogenization in 2 ml of lysis buffer (1 mM NaHCO 3 , 2 mM CaCl 2 , and 5 mM MgCl 2 ). Cellular lysates were centrifuged at 3,000g for 1-2 min to remove intact cells, debris, and nuclei. The resulting supernatant was suspended in an equal volume of 1 M NaI, and the mixture was centrifuged at 48,000g for 25 min. The pellet (membrane fraction) was washed one to two times and suspended in 10 mM Tris and 1 mM EDTA (pH 7.4). Protein concentrations were determined by the Bradford assay and adjusted to 1 mg/ml. The membranes were stored at -70°C until further use. Guanylyl cyclase activity was measured in the presence of phosphatase inhibitors (50 mM sodium fluoride, 1 mM sodium orthovanadate, and 1 mM sodium pyrophosphate), protease inhibitor cocktail (Sigma), and IBMX. cGMP was measured with the use of enzyme immuno assay (EIA) Direct cGMP kit (Assay Design Inc (Ann Arbor, MI)).
Na
? /K ? ATPase activity Na ? /K ? ATPase activity of membrane extractions was measured as inorganic phosphate released in the presence or absence of ouabain as previously described [25] . Na ? /K ? ATPase activity was calculated as the difference between total ATPase activity and the ouabain-insensitive ATPase activity and expressed as nmol phosphate produced per mg protein per min.
Statistics
Values are expressed as the mean ± SD. Differences among groups are determined by ANOVA two-factor for repeated measurements. Results were considered significant at P \ 0.05.
Results

Endogenous NOGCb1 increases GC-A activity
In order to determine whether NOGCb1 effects GC-A activity, ANP-stimulated cGMP formation was evaluated in HK-2 cells in which endogenous NOGCb1 protein expression was suppressed with specific siRNA using transient transfections (Fig. 1, panel A) . ANP-stimulated cGMP formation was decreased in which endogenous NOGCb1 expression was reduced with specific siRNA. GC-A protein expression was the same in control and siRNA treated cells (Fig. 1, panel A-inset) .
To more closely link the membrane-association of NOGCb1 to GC-A activity, guanylyl cyclase activity was measured in membranes prepared from HK-2 cells transfected with siRNA-NOGCb1 (Fig. 1, Panel B) . ANPstimulated guanylyl cyclase activity was significantly less than in membranes from HK-2 cells transfected with a control-scrambled siRNA.
Endogenous NOGCb1 augments ANP-mediated inhibition of basolateral Na/K ATPase in HK-2 cells ANP, via cGMP signaling, and PKG phosphorylation inhibits basolateral Na/K ATPase in renal epithelial cells [26, 27] . So whether endogenous NOGCb1 effects inhibition of Na ? /K ? ATPase by ANP in HK-2 cells was investigated. In these experiments, HK-2 cells were pretreated with L-NAME (1 mM 9 16 h) to inhibit endogenous NO-synthase activity. ANP reduced Na ? /K ? ATPase activity in control cells by approx 40% (Fig. 2) . Na ? /K ? ATPase activity was increased by 40% and ANP-mediated inhibition of Na ? /K ? ATPase activity was reduced in cells treated with siRNA-NOGCb1, suggesting that NOGCb1 enhances inhibition of endogenous Na ? /K ? ATPase activity by ANP in HK2 cells and that this effect is independent of NO signaling.
Over-expression of NOGCb1 increases GC-A activity
In experiments complementary to those in which endogenous expression of NOGCb1 was blocked, NOGCb1 was over-expressed in transiently transfected HK-2 cells (Fig. 3) . Basal and ANP-stimulated cGMP formation were increased 5-10 fold (P \ 0.05). There was a trend toward less stimulation in cells pretreated with L-NAME (1 mM 9 16 h). The effect of ANP on cGMP was blocked by the GC-A inhibitor H-3048 (10 -6 M 9 1 h). GC-A protein expression was the same in vector and NOGCb1 transfected cells (Fig. 3, inset) indicating that NOGCb1 does not regulate GC-A expression.
NOGCb1 can interact with GC-A on the surface membrane of HK-2 Cells
The distribution of YFP-tagged NOGCb1 was examined in HK-2 cells transiently transfected with pIRES-NOGCb1-YFP plasmid and cellular localization determined by YFP yellow fluorescence (Fig. 4a , upper panel NOGCb1). In these cells approximately 50-60% of the NOGCb1 signal was detected in the cell membranes with some cytosolic and nuclear staining. Control vector, pIRES-YFP showed diffused staining throughout the cell (Fig. 4a upper panel, control YFP vector). In order to determine the distribution of NOGCb1 relative to GC-A, cells were co-transfected with His-tagged GC-A (His-GC-A) and immunofluorescence performed with a polyclonal Ab against the 6-His tag. His-GC-A (red) was most concentrated on the cell membrane and in the nucleus (Fig. 4a, upper panel, GC-A) . When the confocal images were overlayed, merger (yellow) of His-GC-A (red) and YFP-NOGCb1 (green) signals was observed (Fig. 4a, upper panel, merged) . In overlays of confocal images with caveolin labeled with rhodamine, there was also merger of signals from YFP-NOGCb1 and His-GC-A (Fig. 4a, middle and lower panels) . Together these results suggest that NOGCb1 is expressed in membrane caveolae with GC-A. To examine whether NOGCb1 interacts with GC-A, immunoprecipitations were performed (Fig. 4b) . Whole cell extracts were prepared from HK-2 cells and immunoprecipitated with affinity purified rabbit polyclonal anti-GC-A antibody directed against the N terminus of GC-A (FabGennix international Inc) (see ''Materials and methods'' section). The resulting immunoprecipitates were assayed with antibody against NOGCb1. NOGCb1 was immunoprecipitated in extracts from HK-2 cells, but not with normal goat IgG as a negative control.
Discussion
The present findings both challenges the traditional paradigm that NO and natriuretic peptide guanylate cyclases function independently of each other and raise the spector of cross-talk between the two pathways. The present results show that the NOGCb1 subunit of NOGC is capable of associating with and regulating GC-A activity/signaling, thereby revealing a novel potential for cross-talk between NO-and ANP-stimulated guanylyl cyclases. Our findings that (1) reducing expression of endogenous NOGCb1 with siRNA and recombinant NOGCb1 decrease and increase, respectively, ANP-stimulated cGMP formation in HK-2 cells; and (2) membrane guanylyl cyclase activity is reduced in cells treated with siRNA to NOGCb1 suggests that NOGCb1 regulates GC-A activity within caveolae. However, the mechanism by which NOGCb1 affects GC-A activity remains to be fully elucidated. It does not appear to be dependent upon NOGC activity since L-NAME, an inhibitor of NOS, did not abolish it. It is possible that other cyclase subunits, in particular of NOGCa associate with peptide-activated GCs, and that the association between NOGCb1 and GC-A proteins involves other proteins in the caveolae-associated signaling complex. Our results suggest a cross talk between ANP/GC-A and NOGCb1. Furthermore, ANP has been reported to stimulate the nitric oxide signaling pathway via activation of nitric oxide synthase in rat kidney [28] , primary cultures of human proximal tubular cells [29] , and rabbit ventricular myocytes [30] . Together, these results suggest a novel cross-talk between these two guanylyl cyclase signaling pathways.
Basolateral Na/K ATPase is a principal regulator of Na reabsorption in the proximal tubule and of natriuresis. cGMP, through cGMP-dependent protein kinase (PKG) reduces basolateral Na/K ATPase activity in renal tubule cells [31, 32] . Changes in basolateral Na/K ATPase activity in HK-2 cells are consistent with changes in cellular cGMP with siRNA to NOGCb1 blocking ANP-mediated inhibition of Na/K ATPase activity. The finding that inhibition of endogenous basolateral caveolae-associated Na/K ATPase activity by ANP in HK-2 cells in which endogenous NOGCb1 expression is reduced by specific siRNA (Fig. 2) provides both collaborative support and suggests physiological relevance of NOGCb1 in ANP signaling [32, 33] . Additionally, it raises the possibility that in previous studies of ANP and GC-A signaling, changes in NOGCb1 could have played a role.
The present confocal image results showed that GC-A and NOGCb1 are concentrated on the cell surface membranes of HK-2 cells and co-localize with caveolin (Fig. 4a) . ANP and GC-B have previously been reported to be expressed in caveolae in cardiac myocytes [11] . NOGCb1 has recently been detected in membranes from neuronal and endothelial cells [14, 15] .
We showed that endogenous GC-A associates with recombinant NOGCb1 protein in HK-2 cells (Fig. 4b) . That GC-A immunoprecipitates NOGCb1 suggests that NOGCb1 is actually associated, via direct and indirect protein-protein interactions, with GC-A in membrane of HK-2 cells. Even though both GC-A and NOGCb1 have few similar regions thought to be important for dimerization [8, 19] , we speculate that the interaction is most likely indirect, involving other caveolae-associated proteins, e.g., caveolin. While we are proposing that caveolae-associated GC-A targets NOGCb1 to the membrane, there is evidence for other proteins associated with caveolae. Both B-type natriuretic receptor guanylate cyclase (GC-B) and NOGCb1 localize in caveolae in cardiac myocytes [11] and in rat aortic and corpus cavernosus endothelial cells [16, 17] , respectively. An endothelial nitric oxide synthase (eNOS), NOGC and cGMP-dependent protein kinase (PKG) signaling ''complex'' in endothelial cell caveolae has been demonstrated [16, 17] .
That NOGCb1 immunoprecipitates with GC-A and colocalizes with caveolin indicates that it too is in caveolae in HK-2 cells. Caveolae association of NOGC has recently been both reported in cavernosal and aortic endothelial cells and shown to be critical to NO-induced smooth muscle relaxation and erection [16, 17] . Whether NOGCb1 association with caveolae is regulated in HK-2 cells was not addressed in the present study and remains to be determined.
